We are pleased that the district court decision on invalidity has been upheld. We continue to believe that our... businesswire.com/news/home/2…
StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data: investor.stemcellsinc.com/ph…
$STEM's Phase II Pathway Study for Cervical #SpinalCordInjury featured in @NewshubNZ: newshub.co.nz/world/stem-cel…
2
$STEM's Phase II Pathway Study for Cervical #SpinalCordInjury featured in @CBSNewYork: cbsnews.com/news/experimenta…
$STEM's Phase II Pathway Study for Cervical #SpinalCordInjury featured in @CBSNewYork: cbsnews.com/videos/morning-r…
$STEM to Report 12-Month Cohort I Data from its Phase II Pathway Study: investor.stemcellsinc.com/ph… #SpinalCordInjury
StemCells, Inc. Announces 1-for-12 Reverse Stock Split: investor.stemcellsinc.com/ph… $STEM
$STEM to Participate in the 3rd Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas, NV: investor.stemcellsinc.com/ph…
$STEM Presents Interim Results from its Phase II Pathway Study in Chronic Cervical #spinalcordinjury at #ASIA2016: investor.stemcellsinc.com/ph…
$STEM's Pathway clinical trial in #SpinalCordInjury featured in @DowneyPatriot: thedowneypatriot.com/article…
StemCells, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update: investor.stemcellsinc.com/ph… $STEM
$STEM Pathway Study patient recruitment featured in this @U2FP_W2W blog post: spinalcordresearchandadvocac… #SpinalCordInjury
StemCells, Inc. Announces Webcast to Discuss Fourth Quarter 2015 Financial Results investor.stemcellsinc.com/ph… $STEM
Nominate StemCells, Inc. for the New Economy Awards 2016 here theneweconomy.com/awards @NewEconomyMag $STEM
StemCells, Inc. Announces Closing of $8 Million Public Offering: investor.stemcellsinc.com/ph… $STEM
StemCells, Inc. Announces Pricing of Public Offering to Raise $8.1 Million: investor.stemcellsinc.com/ph… $STEM
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants: investor.stemcellsinc.com/ph… $STEM
StemCellsInc retweeted
$STEM New #SNNLive #Video #Interview with StemCells, Inc. on Stock News Now: ow.ly/YSrPp @StemCellsInc #SpinalCordInjury
$STEM featured in @StockNewsNow: Research & Development of Cell-based Therapies for the Treatment of CNS Disorders: stocknewsnow.com/commentary/…
$STEM's Pathway clinical trial in #SpinalCordInjury featured in @PittsburghPG: post-gazette.com/news/health…

